Literature DB >> 2897787

Determination of the spectrum of beta-thalassemia genes in Spain by use of dot-blot analysis of amplified beta-globin DNA.

S Amselem1, V Nunes, M Vidaud, X Estivill, C Wong, L d'Auriol, D Vidaud, F Galibert, M Baiget, M Goossens.   

Abstract

We have delineated the molecular lesions causing beta-thalassemia in Spain, a country that has witnessed the passage of different Mediterranean populations over the centuries, in order to evaluate the extent of heterogeneity of these mutations and to make possible simplified prenatal diagnosis of the disorder in that country. The use of the polymerase chain-reaction (PCR) technique to preferentially amplify beta-globin DNA sequences that contain the most frequent beta-thalassemia mutations in Mediterraneans enabled us to rapidly analyze 58 beta-thalassemia alleles in a dot-blot format either by hybridization with allele-specific radiolabeled oligonucleotide probes or by direct sequence analysis of the amplification product. The Spanish population carries seven different beta-thalassemia mutations; the nonsense codon 39 is predominant (64%), whereas the IVS1 position 110 mutation, the most common cause of beta-thalassemia in the eastern part of the Mediterranean basin, is underrepresented (8.5%). The IVS1 mutation at position 6 accounts for 15% of the defects and leads to a more severe form of beta+-thalassemia than originally described in most of the patients we studied. In this study, we demonstrate further the usefulness of the dot-blot hybridization of PCR-amplified genomic DNA in both rapid population surveys and prenatal diagnosis of beta-thalassemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897787      PMCID: PMC1715291     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  Two cloned beta thalassemia genes are associated with amber mutations at codon 39.

Authors:  R Pergolizzi; R A Spritz; S Spence; M Goossens; Y W Kan; A Bank
Journal:  Nucleic Acids Res       Date:  1981-12-21       Impact factor: 16.971

2.  DNA analysis in the diagnosis of hemoglobin disorders.

Authors:  M Goossens; Y Y Kan
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

3.  Nonrandom association of polymorphic restriction sites in the beta-globin gene cluster.

Authors:  S E Antonarakis; C D Boehm; P J Giardina; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

4.  Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.

Authors:  S H Orkin; H H Kazazian; S E Antonarakis; S C Goff; C D Boehm; J P Sexton; P G Waber; P J Giardina
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

5.  A new nonsense mutation as the molecular basis for beta thalassaemia.

Authors:  J Gorski; M Fiori; B Mach
Journal:  J Mol Biol       Date:  1982-01-25       Impact factor: 5.469

6.  Polymorphism of DNA sequence in the beta-globin gene region. Application to prenatal diagnosis of beta 0 thalassemia in Sardinia.

Authors:  Y W Kan; K Y Lee; M Furbetta; A Angius; A Cao
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

7.  The peculiar spectrum of beta-thalassemia genes in Tunisia.

Authors:  J Chibani; M Vidaud; P Duquesnoy; J L Bergé-Lefranc; M Pirastu; F Ellouze; J Rosa; M Goossens
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

8.  Beta + thalassemia--Portuguese type: clinical, haematological and molecular studies of a newly defined form of beta thalassaemia.

Authors:  G P Tamagnini; M C Lopes; M E Castanheira; J S Wainscoat; W G Wood
Journal:  Br J Haematol       Date:  1983-06       Impact factor: 6.998

9.  Base substitution in an intervening sequence of a beta+-thalassemic human globin gene.

Authors:  R A Spritz; P Jagadeeswaran; P V Choudary; P A Biro; J T Elder; J K deRiel; J L Manley; M L Gefter; B G Forget; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  beta zero thalassemia in Sardinia is caused by a nonsense mutation.

Authors:  R F Trecartin; S A Liebhaber; J C Chang; K Y Lee; Y W Kan; M Furbetta; A Angius; A Cao
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

View more
  14 in total

1.  The molecular basis of beta-thalassemia in Turkey.

Authors:  A N Başak; H Ozçelik; A Ozer; A Tolun; M Aksoy; L Ağaoğlu; F Ridolfi; L Ulukutlu; N Akar; A Gürgey
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

2.  Beta-thalassaemia: molecular pathogenesis and clinical variability.

Authors:  A E Kulozik
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

3.  Molecular characterization of beta-thalassemia mutations in Egypt.

Authors:  A Novelletto; M Hafez; G Deidda; A Di Rienzo; L Felicetti; H el-Tahan; Z el Morsi; M el-Ziny; Y al-Tonbary; A Sittien
Journal:  Hum Genet       Date:  1990-08       Impact factor: 4.132

4.  A 5' splice-region G----C mutation in exon 1 of the human beta-globin gene inhibits pre-mRNA splicing: a mechanism for beta+-thalassemia.

Authors:  M Vidaud; R Gattoni; J Stevenin; D Vidaud; S Amselem; J Chibani; J Rosa; M Goossens
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing.

Authors:  D W Yandell; T P Dryja
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

Review 6.  The polymerase chain reaction: an improved method for the analysis of nucleic acids.

Authors:  H P Vosberg
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

7.  Direct mutation analysis of beta-thalassemia genes in families of various ethnic origins residing in Germany.

Authors:  J Schnee; A Eigel; J Horst
Journal:  Blut       Date:  1989-09

8.  Molecular characterisation of beta thalassaemia heterozygotes in Brazil.

Authors:  C S Martins; A S Ramalho; M F Sonati; M S Gonçalves; F F Costa
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

Review 9.  Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants.

Authors:  J Flint; R M Harding; J B Clegg; A J Boyce
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

10.  Hb S/β-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.

Authors:  André R Belisário; Anna B Carneiro-Proietti; Ester Cerdeira Sabino; Aderson Araújo; Paula Loureiro; Cláudia Máximo; Miriam V Flor-Park; Daniela D O W Rodrigues; Mina Cintho Ozahata; Christopher McClure; Rosimere Afonso Mota; Isabel C Gomes Moura; Brian Custer; Shannon Kelly
Journal:  Hemoglobin       Date:  2020-03-16       Impact factor: 0.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.